CVS Health Balance Sheet Health
Financial Health criteria checks 2/6
CVS Health has a total shareholder equity of $77.1B and total debt of $64.7B, which brings its debt-to-equity ratio to 83.9%. Its total assets and total liabilities are $255.6B and $178.5B respectively. CVS Health's EBIT is $9.3B making its interest coverage ratio 11.6. It has cash and short-term investments of $12.7B.
Key information
83.92%
Debt to equity ratio
US$64.71b
Debt
| Interest coverage ratio | 11.6x |
| Cash | US$12.65b |
| Equity | US$77.11b |
| Total liabilities | US$178.48b |
| Total assets | US$255.59b |
Recent financial health updates
Is CVS Health (NYSE:CVS) A Risky Investment?
Mar 07
CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21Recent updates
CVS Health: Firing On All Cylinders, Thanks To The Promising Reversal
May 11CVS Health (NYSE:CVS) Will Pay A Dividend Of $0.665
Apr 08CVS Health: I Don't Understand The Fuss, But The Worst Is Behind
Mar 30CVS Health (NYSE:CVS) Is Paying Out A Dividend Of $0.665
Mar 25Is CVS Health (NYSE:CVS) A Risky Investment?
Mar 07CVS Health: Incremental Improvement Best Hope For 2025 (Rating Downgrade)
Feb 26Market Might Still Lack Some Conviction On CVS Health Corporation (NYSE:CVS) Even After 25% Share Price Boost
Feb 17Earnings Beat: CVS Health Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 14CVS Health Jumps On Q4 Earnings Beat, But Downgrading To Hold
Feb 13CVS Health Isn't Going To The Dogs
Jan 17CVS Health: An Attractive 5.8% Safe Yield For Now
Jan 10Market Cool On CVS Health Corporation's (NYSE:CVS) Earnings Pushing Shares 25% Lower
Dec 26CVS Health: When The Industry Is In Crisis, Don't Pick The Weaker Players
Dec 10There May Be Some Bright Spots In CVS Health's (NYSE:CVS) Earnings
Nov 19CVS Health: Cheap But No Signs Of Turnaround (Yet)
Nov 06CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet
Nov 03
Why CVS’s Valuation Signals Opportunity
Oct 30CVS Health has just faced a stock decline of about 10% after its preliminary Q3 earnings miss, which made the entire market aware. The decline is contributed largely to a $1.1 billion charge connectedCVS Health Stock Dip: Undervalued And Ready For A Turnaround
Oct 24CVS Health: Glenview's Activism Ramps Up Pressure On Management
Sep 30CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)
Sep 10A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price
Aug 08CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run
Aug 07Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden
Jul 21CVS Health: A Better Investment Than Walgreens Boots Alliance
Jul 09Vltava Fund - CVS Health Corp.: Why We Sold CVS
Jul 03CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell
Jun 21The Correct Play On CVS Health
Jun 06CVS Health: Downside Movement Is Overdramatic
May 26CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity
May 15Financial Position Analysis
Short Term Liabilities: CVS's short term assets ($73.2B) do not cover its short term liabilities ($89.0B).
Long Term Liabilities: CVS's short term assets ($73.2B) do not cover its long term liabilities ($89.5B).
Debt to Equity History and Analysis
Debt Level: CVS's net debt to equity ratio (67.5%) is considered high.
Reducing Debt: CVS's debt to equity ratio has reduced from 108.3% to 83.9% over the past 5 years.
Debt Coverage: CVS's debt is not well covered by operating cash flow (13.5%).
Interest Coverage: CVS's interest payments on its debt are well covered by EBIT (11.6x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/16 04:20 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CVS Health Corporation is covered by 61 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Harshit Gupta | Accountability Research Corporation |
| Christopher Graja | Argus Research Company |
| Samuel Hudson | Atlantic Equities LLP |